Hunan Hansen Pharmaceutical Co Ltd
SZSE:002412
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
5.55
7.17
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Dividends
Dividend Yield
Hunan Hansen Pharmaceutical Co Ltd
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Hunan Hansen Pharmaceutical Co Ltd
Hunan Hansen Pharmaceutical Co Ltd have
decreased
by 0%.
Payout Ratio
Hunan Hansen Pharmaceutical Co Ltd
| Current Payout | |
| Min Payout | |
| Max Payout | |
| Average Payout | |
| Median Payout |
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for
Hunan Hansen Pharmaceutical Co Ltd is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Peers Comparison
Shareholder Yield
Price Appreciation
Price
Hunan Hansen Pharmaceutical Co Ltd
| Average Annual Return | -0.44% |
| Standard Deviation of Annual Returns | 13.3% |
| Max Drawdown | -53% |
| Market Capitalization | 3.4B CNY |
| Shares Outstanding | 503 200 000 |
| Percentage of Shares Shorted |
N/A
|
Stock Splits
Hunan Hansen Pharmaceutical Co Ltd's latest stock split occurred on May 30, 2019
The company executed a 1-for-1 stock split, meaning that for every share held, investors received 1 new share.
Before the split, Hunan Hansen Pharmaceutical Co Ltd traded at 12.2 per share. Afterward, the share price was about 11.6351.
The adjusted shares began trading on May 30, 2019. This was Hunan Hansen Pharmaceutical Co Ltd's 3rd stock split, following the previous one in May 23, 2014.